Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Hansen's Disease in Costa Rica (2018-2025)

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorCaja Costarricense de Seguro Social

About this trial

The goal of this observational retrospective study is to characterize the epidemiologic, clinical, diagnostic, and therapeutic features of Hansen's disease cases in Costa Rica between 2018 and 2025. The main questions it aims to answer are:

What are the epidemiologic and clinical characteristics of confirmed Hansen's disease cases in Costa Rica?

What diagnostic methods, treatments, complications, and outcomes are observed in routine care?

All confirmed Hansen's disease cases recorded in national surveillance and with available clinical records during 2018-2025 will be included. Data will be obtained from electronic health records and Ministry of Health reports without participant contact.

Eligibility criteria

Qualifiers

Confirmed diagnosis of Hansen's disease.

Diagnosis between 1 January 2018 and 31 December 2025.

Any age or sex.

Available digital clinical record.

Disqualifiers

Cases whose diagnosis was reviewed and reclassified as another disease.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed